Literature DB >> 32295677

Developing and Testing Message Strategies to Reduce Indoor Tanning.

Amy B Jordan1, Amy Bleakley2, Julia M Alber3, DeAnn Lazovich4, Karen Glanz5.   

Abstract

Objectives: Indoor tanning, which is most common among 18-25-year-old white women, increases the risk of skin cancer. To address this problem, we developed and tested messages with a national sample of indoor tanners to determine beliefs that would encourage them to quit.
Methods: Messages discouraging indoor tanning using different persuasive themes (skin cancer risk, appearance risk, well-being enhancement) were developed based on formative research and a review of intervention efforts. We conducted an online experiment to test the final messages with a national sample of 480 indoor tanners.
Results: Messages that emphasized skin cancer risk out-performed messages that focused on well-being enhancement or damage to appearance in terms of intention to quit indoor tanning. Analyses revealed 2 key mediators: perceived argument strength and beliefs related to the effects of indoor tanning. Conclusions: Theory- and evidence-informed public health communications can contribute to improving health-related behaviors. Focusing on the risk of skin cancer may be the most effective strategy to reduce indoor tanning among young white women.

Entities:  

Mesh:

Year:  2020        PMID: 32295677     DOI: 10.5993/AJHB.44.3.2

Source DB:  PubMed          Journal:  Am J Health Behav        ISSN: 1087-3244


  2 in total

1.  UVR-sensor wearable device intervention to improve sun behaviors and reduce sunburns in melanoma survivors: study protocol of a parallel-group randomized controlled trial.

Authors:  Rachel I Vogel; Rebekah H Nagler; Rehana L Ahmed; Katherine Brown; Xianghua Luo; Brian C Martinson; DeAnn Lazovich
Journal:  Trials       Date:  2020-11-23       Impact factor: 2.279

Review 2.  Digital interventions for promoting sun protection and skin self-examination behaviors: A systematic review.

Authors:  Zhaomeng Niu; Trishnee Bhurosy; Carolyn J Heckman
Journal:  Prev Med Rep       Date:  2022-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.